University of South Florida: Parkinson Disease trials
The registry lists 10 Parkinson Disease studies with University of South Florida as lead sponsor. 1 are open to participants now and 1 have results posted.
Phase 1 1Phase 2 2Phase 3 1Phase 4 4No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Brain Dopamine BiomarkerNot yet recruitingNCT07748715
- Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's DiseaseCompletedNCT01018264Phase 4Results posted
- Anodic Stimulation in Parkinson's DiseaseActive, not recruitingNCT07798999Not applicable
- i-BiSSkApp for Swallowing Rehabilitation in Parkinson's DiseaseStatus unknownNCT05837520Phase 1
- Sagene 2014 - Parkinson's Disease and Erectile DysfunctionStatus unknownNCT02225548Phase 4
- A Phase 2A Trial of EPI-743 for Patients With Parkinson's DiseaseCompletedNCT01923584Phase 2
- Glutathione (GSH) In The Treatment of Parkinson's DiseaseCompletedNCT01177319Phase 2
- Brain Fitness in Parkinson's DiseaseCompletedNCT01155349Phase 3
- Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson's DiseaseWithdrawnNCT00584090Phase 4
- Keppra IV for the Treatment of Motor Fluctuations in Parkinson's DiseaseWithdrawnNCT00584025Phase 4